Short answer
ASPEN AEROGELS INC (ASPN) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year FY2025 results announced Feb 25, 2026 (fiscal year ended Dec 31, 2025).
ASPEN AEROGELS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year FY2025 results announced Feb 25, 2026 (fiscal year ended Dec 31, 2025)
- Full financials in Exhibit 99.1 press release: primary source for revenue, margins, and EPS detail
- "Financial Outlook" section excluded from SEC incorporation: guidance carries higher uncertainty/non-GAAP risk
Item 7.01 · Regulation FD Disclosure
- Aspen Aerogels updated its Financial Outlook via Reg FD press release: forward-looking guidance disclosed to ensure broad investor access
- Reg FD filing signals material guidance update that could move consensus estimates; full details in the referenced press release exhibit
- Investors should review the attached press release exhibit for specific revenue, margin, or volume guidance figures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ASPEN AEROGELS INC 8-K filings
Get the next ASPN 8-K as it lands
Follow ASPN for push alerts, or ask the research agent what this filing means.